TY  - JOUR
AU  - Hernández Jiménez, Macarena
AU  - Moro Sánchez, María Ángeles
AU  - Lizasoaín Hernández, Ignacio
AU  - Ribo, Marc
PY  - 2023
DO  - 10.1001/jamaneurol.2023.1660
UR  - https://hdl.handle.net/20.500.14352/113751
T2  - JAMA Neurology
AB  - Importance: ApTOLL is a TLR4 antagonist with proven preclinical neuroprotective effect and a safe profile in healthy volunteers.Objective: To assess the safety and efficacy of ApTOLL in combination with endovascular treatment (EVT) for patients with...
LA  - eng
M2  - 779
PB  - Jama
KW  - Brain ischemia
KW  - Cerebral infarction
TI  - Safety and Efficacy of ApTOLL in Patients With Ischemic Stroke Undergoing Endovascular Treatment: A Phase 1/2 Randomized Clinical Trial
TY  - journal article
VL  - 80
ER  -